Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane compounds

US5164401A · kind A · utility

Assignee

• Kali-Chemie Pharma GmbH · DE

Inventors

• Kurt Burow · Hannover, DE
• Gerd Buschmann · Velbert, DE
• Arman Farjam · Celle, DE
• Ulrich Kuehl · Hannover, DE
• Gerda Varchmin · Hannover, DE
• Deiter Ziegler · Ronnenberg, DE
• Uwe Schoen · Burgdorf, DE

Key dates

• Filing date: Jun 17, 1991
• Grant date: Nov 17, 1992
• Expiry date: Jun 17, 2011

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treating a mammal in need of diruetic treatment by administering an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound, diuretic pharmaceutical compositions containing an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound; and previously unknown diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compounds containing an optionally substituted phenylalkyl group in the 3-position.